Immunotherapy of Cytotoxic T Cell–resistant Tumors by T Helper 2 Cells: An Eotaxin and STAT6-dependent Process

Currently most attempts at cancer immunotherapy involve the generation of CD8(+) cytotoxic T lymphocytes (CTLs) against tumor-associated antigens. Many tumors, however, have been immunoselected to evade recognition by CTLs and thus alternative approaches to cancer immunotherapy are urgently needed....

Descripción completa

Detalles Bibliográficos
Autores principales: Mattes, Joerg, Hulett, Mark, Xie, Wei, Hogan, Simon, Rothenberg, Marc E., Foster, Paul, Parish, Christopher
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2003
Materias:
Brief Definitive Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193835/
https://www.ncbi.nlm.nih.gov/pubmed/12566422
http://dx.doi.org/10.1084/jem.20021683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193835/
https://www.ncbi.nlm.nih.gov/pubmed/12566422
http://dx.doi.org/10.1084/jem.20021683

Ejemplares similares